Glycogen Synthase 2 Antikörper
-
- Target Alle Glycogen Synthase 2 (GYS2) Antikörper anzeigen
- Glycogen Synthase 2 (GYS2) (Glycogen Synthase 2, Liver (GYS2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Glycogen Synthase 2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human GYS2
- Isotyp
- IgG
-
-
- Applikationshinweise
- IHC 1:100-1:300
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- Glycogen Synthase 2 (GYS2) (Glycogen Synthase 2, Liver (GYS2))
- Andere Bezeichnung
- GYS2 (GYS2 Produkte)
- Hintergrund
- The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content.
- UniProt
- P54840
- Pathways
- AMPK Signaling, Cellular Glucan Metabolic Process
-